Cargando…

Lipid mediators in plasma of autism spectrum disorders

BACKGROUND: Inflammation is increasingly recognized as being of both physiological and pathological importance in the immature brain. Cerebellar pathology occurs in autism, as a neurodevelopmental disorder with genetic and environmental origins. The genesis of this disorder is still not understood b...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ansary, Afaf, Al-Ayadhi, Laila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557222/
https://www.ncbi.nlm.nih.gov/pubmed/23170784
http://dx.doi.org/10.1186/1476-511X-11-160
_version_ 1782257288107524096
author El-Ansary, Afaf
Al-Ayadhi, Laila
author_facet El-Ansary, Afaf
Al-Ayadhi, Laila
author_sort El-Ansary, Afaf
collection PubMed
description BACKGROUND: Inflammation is increasingly recognized as being of both physiological and pathological importance in the immature brain. Cerebellar pathology occurs in autism, as a neurodevelopmental disorder with genetic and environmental origins. The genesis of this disorder is still not understood but inflammation in utero or early in childhood is an environmental risk factor. METHODS: Prostaglandin E2 (PGE2), cysteinyl leukotriene as two important lipid mediators together with 8 isoprostane as marker of oxidative stress were measured using ELISA in plasma of 20 male autistic patients compared to 19 age and gender matching control participants. RESULTS: PGE2, leukotrienes and isoprostanes recorded significantly elevated levels in autistics compared to controls. Role of these measured parameters in inflammation and autoimmunity as two etiological factors in autism were discussed in details. CONCLUSION: Receiver Operating Characteristic (ROC) curve analysis shows satisfactory values of area under the curve (AUC) which could reflect the high degree of specificity and sensitivity of the altered PGE2, leukotrienes and isoprostanes as predictive biomarkers in autistic patients from Saudi Arabia.
format Online
Article
Text
id pubmed-3557222
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35572222013-01-31 Lipid mediators in plasma of autism spectrum disorders El-Ansary, Afaf Al-Ayadhi, Laila Lipids Health Dis Research BACKGROUND: Inflammation is increasingly recognized as being of both physiological and pathological importance in the immature brain. Cerebellar pathology occurs in autism, as a neurodevelopmental disorder with genetic and environmental origins. The genesis of this disorder is still not understood but inflammation in utero or early in childhood is an environmental risk factor. METHODS: Prostaglandin E2 (PGE2), cysteinyl leukotriene as two important lipid mediators together with 8 isoprostane as marker of oxidative stress were measured using ELISA in plasma of 20 male autistic patients compared to 19 age and gender matching control participants. RESULTS: PGE2, leukotrienes and isoprostanes recorded significantly elevated levels in autistics compared to controls. Role of these measured parameters in inflammation and autoimmunity as two etiological factors in autism were discussed in details. CONCLUSION: Receiver Operating Characteristic (ROC) curve analysis shows satisfactory values of area under the curve (AUC) which could reflect the high degree of specificity and sensitivity of the altered PGE2, leukotrienes and isoprostanes as predictive biomarkers in autistic patients from Saudi Arabia. BioMed Central 2012-11-21 /pmc/articles/PMC3557222/ /pubmed/23170784 http://dx.doi.org/10.1186/1476-511X-11-160 Text en Copyright ©2012 El-Ansary and Al-Ayadhi; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
El-Ansary, Afaf
Al-Ayadhi, Laila
Lipid mediators in plasma of autism spectrum disorders
title Lipid mediators in plasma of autism spectrum disorders
title_full Lipid mediators in plasma of autism spectrum disorders
title_fullStr Lipid mediators in plasma of autism spectrum disorders
title_full_unstemmed Lipid mediators in plasma of autism spectrum disorders
title_short Lipid mediators in plasma of autism spectrum disorders
title_sort lipid mediators in plasma of autism spectrum disorders
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557222/
https://www.ncbi.nlm.nih.gov/pubmed/23170784
http://dx.doi.org/10.1186/1476-511X-11-160
work_keys_str_mv AT elansaryafaf lipidmediatorsinplasmaofautismspectrumdisorders
AT alayadhilaila lipidmediatorsinplasmaofautismspectrumdisorders